Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Yvette J. E. Sloot"'
Autor:
Yvette J. E. Sloot, Marcel J. R. Janssen, Antonius E. van Herwaarden, Robin P. Peeters, Romana T. Netea-Maier, Johannes W. A. Smit
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-7 (2019)
Abstract Sufficient thyroid iodine uptake is needed to ensure effective radioactive iodine (RAI) treatment, which is mediated by the sodium-iodide symporter (NIS). Activation of AMP-activated-protein-kinase (AMPK), leads to decreased NIS expression a
Externí odkaz:
https://doaj.org/article/8cbde1386042484b97308c46c706c4ac
Autor:
Marcel J.R. Janssen, Antonius E. van Herwaarden, Robin P. Peeters, Yvette J E Sloot, Romana T. Netea-Maier, Johannes W. A. Smit
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-7 (2019)
Scientific Reports, 9
Scientific Reports
Scientific Reports, 9:5396. Nature Publishing Group
Scientific Reports, 9
Scientific Reports
Scientific Reports, 9:5396. Nature Publishing Group
Contains fulltext : 202949.pdf (Publisher’s version ) (Open Access) Sufficient thyroid iodine uptake is needed to ensure effective radioactive iodine (RAI) treatment, which is mediated by the sodium-iodide symporter (NIS). Activation of AMP-activat
Autor:
Yvette J E Sloot, Dennis M. de Graaf, Katrin Rabold, Romana T. Netea-Maier, Bas Heinhuis, Thomas Ulas, Kristian Händler, Leo A. B. Joosten, Mihai G. Netea, Johannes W. A. Smit, Joachim L. Schultze
Publikováno v:
Cellular oncology 42(5), 691-703 (2019). doi:10.1007/s13402-019-00457-9
Cellular Oncology (2011. Print), 42, 5, pp. 691-703
Cellular Oncology (2011. Print), 42, 691-703
Cellular Oncology (2011. Print), 42, 5, pp. 691-703
Cellular Oncology (2011. Print), 42, 691-703
Interleukin 32 (IL-32) is a pro-inflammatory cytokine of which different isoforms have been identified. Recently, IL-32 has been shown to act as a potent inducer of cell migration in several types of cancer. Although previous research showed that IL-
Autor:
Martin Jaeger, Leo A. B. Joosten, Yang Li, Romana T. Netea-Maier, Simone J.C.F.M. Moorlag, Charlotte de Bree, Johannes W. A. Smit, Yvette J E Sloot, Rob ter Horst, Irma Joosten, Vera P. Mourits, Valerie A. C. M. Koeken, Heidi Lemmers, Antonius E. van Herwaarden, Mihai G. Netea, Marco Medici, Hans J. P. M. Koenen, Helga Dijkstra, Xiaojing Chu
Publikováno v:
Immunology, 163, 155-168
Immunology, 163, 2, pp. 155-168
Immunology
Jaeger, M, Sloot, Y J E, Horst, R T, Chu, X, Koenen, H J P M, Koeken, V A C M, Moorlag, S J C F M, de Bree, C J, Mourits, V P, Lemmers, H, Dijkstra, H, Medici, M, van Herwaarden, A E, Joosten, I, Joosten, L A B, Li, Y, Smit, J W A, Netea, M G & Netea-Maier, R T 2021, ' Thyrotrophin and thyroxine support immune homeostasis in humans ', Immunology, vol. 163, no. 2, pp. 155-168 . https://doi.org/10.1111/imm.13306
Immunology. Wiley-Blackwell
Immunology, 163, 2, pp. 155-168
Immunology
Jaeger, M, Sloot, Y J E, Horst, R T, Chu, X, Koenen, H J P M, Koeken, V A C M, Moorlag, S J C F M, de Bree, C J, Mourits, V P, Lemmers, H, Dijkstra, H, Medici, M, van Herwaarden, A E, Joosten, I, Joosten, L A B, Li, Y, Smit, J W A, Netea, M G & Netea-Maier, R T 2021, ' Thyrotrophin and thyroxine support immune homeostasis in humans ', Immunology, vol. 163, no. 2, pp. 155-168 . https://doi.org/10.1111/imm.13306
Immunology. Wiley-Blackwell
Summary The endocrine and the immune systems interact by sharing receptors for hormones and cytokines, cross‐control and feedback mechanisms. To date, no comprehensive study has assessed the impact of thyroid hormones on immune homeostasis. By stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e77966ad08c0874025b124cc14bb3c80
http://hdl.handle.net/2066/235364
http://hdl.handle.net/2066/235364
Autor:
Romana T. Netea-Maier, Yvette J E Sloot, Iris D. Nagtegaal, Ilse van Engen-van Grunsven, Carlijn van de Water, Jan W. A. Smit, Niek Hugen
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 105, 3, pp. E299-E306
The Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, 105, E299-E306
The Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, 105, E299-E306
Background Metastatic disease is the main cause of cancer-related mortality in thyroid carcinoma (TC) patients. Clinical studies have suggested differences in metastatic patterns between the different subtypes of TC. This study systematically evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d75e9485591f457f782f9207fe30740e
https://hdl.handle.net/2066/218673
https://hdl.handle.net/2066/218673
Autor:
Vera P. Mourits, Bree Charlotte De, Yang Li, M.G. Netea, Martin Jaeger, Hans J. M. P. Koenen, R.T. Netea-Maier, Herwaarden Antonius van, Jan W. A. Smit, Xiaojing Chu, Yvette J E Sloot, Horst Rob Ter, Irma Joosten, Valerie A.C.M. Koeken, Simone J.C.F.M. Moorlag
Publikováno v:
Endocrine Abstracts.
Autor:
Yvette J E Sloot, Nicoline Hoogerbrugge, Katrin Rabold, Romana T. Netea-Maier, Johannes W. A. Smit, Mihai G. Netea
Publikováno v:
Oncogene, 38, 3743-3755
Oncogene, 38, 19, pp. 3743-3755
Oncogene, 38, 19, pp. 3743-3755
PTEN hamartoma tumor syndrome (PHTS) is caused by inactivating germline PTEN mutations with subsequent activation of Akt-mTOR signaling, leading to an increased risk of developing thyroid carcinoma (TC). Activation of Akt-mTOR signaling is essential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bee7cfa709e7d6ebbf0797839625873
http://hdl.handle.net/2066/203680
http://hdl.handle.net/2066/203680
Autor:
Yvette J E, Sloot, Katrin, Rabold, Mihai G, Netea, Johannes W A, Smit, Nicoline, Hoogerbrugge, Romana T, Netea-Maier
Publikováno v:
Oncogene. 38(19)
PTEN hamartoma tumor syndrome (PHTS) is caused by inactivating germline PTEN mutations with subsequent activation of Akt-mTOR signaling, leading to an increased risk of developing thyroid carcinoma (TC). Activation of Akt-mTOR signaling is essential
Publikováno v:
Seminars in Immunology, 38, pp. 24-32
Seminars in Immunology, 38, 24-32
Seminars in Immunology, 38, 24-32
Contains fulltext : 200195.pdf (Publisher’s version ) (Closed access) Interleukin 32 (IL-32) is a proinflammatory cytokine involved in the development of several diseases, including cancer. IL-32 is a rather peculiar cytokine because its protein st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d4fd819e2dfce448a371a5c8e49ce6f
https://doi.org/10.1016/j.smim.2018.03.004
https://doi.org/10.1016/j.smim.2018.03.004
Autor:
Joakim Schulze, R.T. Netea-Maier, Mirela Sanda Petrulea, Carmen Emanuela Georgescu, Benno Küsters, Yvette J E Sloot, Leo A. B. Joosten, Theo S. Plantinga, Rob J. W. Arts, Marika H Tesselaar, Johannes W Smit, Bas Heinhuis, M.G. Netea, Sander Tuit
Publikováno v:
Endocrine Abstracts.